Sage Journals: Discover world-class research

Free access

Review article

First published 2008-09

Review: Neutralizing antibodies against interferon-beta

Per Soelberg Sorensen

Therapeutic Advances in Neurological Disorders

Retricted access

Other

First published 2010-01

Neutralizing antibodies to 500 μg interferon beta-1b: 28-month results of the IDEAS extension trial

MH Gottesman, S. Friedman-Urevich, E. Boylan [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2009-12

Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study

Claudia Gneiss, Pia-Maria Koudouovoh-Tripp, Stefan Ropele [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-06

Measuring and management of Anti-Interferon Beta Antibodies in subjects with Multiple Sclerosis

Rachel A Farrell, Gavin Giovannoni

Multiple Sclerosis Journal

Open access

Research article

First published 2017-12

Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis

Alexander Y Lau, WK Ip, Cheryl Au [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Other

First published 2008-03

Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta

R. Farrell, R. Kapoor, S. Leary [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2004-10

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity

C Gneiss, M Reindl, A Lutterotti [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2009-05

The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis

N Koch-Henriksen, PS Sorensen, K Bendtzen [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-5

Clinical relevance of anti-drug antibodies with interferon beta-1b therapy in multiple sclerosis

M. Cantillon, I. Antonijevic

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-5

Persistency of neutralizing antibodies depends on titer and interferon-beta preparation

Harald Hegen, Manuel Schleiser, Claudia Gneiss [...]

Multiple Sclerosis Journal

Search results